As part of its rulemaking process, the U.S. Food and Drug Administration (FDA) is required to conduct an economic impact analysis that assesses the costs and benefits of proposed regulations and to select the option that maximizes the net economic benefit. There are numerous challenges inherent in conducting this type of analysis, from fully.assessing the various costs and benefits of proposed rules to quantifying these costs and benefits, often with incomplete data and evidence. The comments provided to FDA on the economic impact analysis contained in its proposed rule on required warnings for cigarette packages and advertisements highlighted these challenges. The overarching aim of this project is to produce new evidence that will inform and refine the FDA's economic impact assessments of future proposed rules. This will be done through a combination of behavioral economics experiments with original data collection, acquisition of existing archival, survey, and commercial databases, and merged data analyses that address the issues discussed above, as well as others that emerge in coming years. To accomplish this, a variety of . activities vvili be done to address three specific aims that together address most of the FDA's research priorities around understanding the role of economics and policies on tobacco use and perceptions.
Aim 1 : assess the impact of FDA regulatory actions and other tobacco control policies on tobacco use and related outcomes, including the impact on trajectories of tobacco use among young people and adults, the differential impact of these actions on disparate populations, and the differential impact on the use of traditional and emerging tobacco products.
Aim 2 : Assess the impact of FDA regulatory actions and other tobacco control policies on the consumer surplus obtained by tobacco users through a behavioral economics experiment that will quantify the extent of present bias, projection bias, and time inconsistencies in decisions about tobacco use and the implications of these biases for assessing changes in consumer surplus.
Aim 3 : Extend the range of costs and benefits including in assessing the economic impact of FDA regulatory actions to include a broader set of health and economic benefits than that included in previous FDA assessments.
There are numerous challenges inherent in conducting the type of economic impact analysis FDA is required to conduct as part of its rulemaking process. This project will produce new evidence that addresses these challenges and better informs the FDA's economic impact assessments of future proposed rules concerning tobacco products.
|Yang, Bo; Owusu, Daniel; Popova, Lucy (2018) Testing messages about comparative risk of electronic cigarettes and combusted cigarettes. Tob Control :|
|Gibson, Laura A; Creamer, MeLisa R; Breland, Alison B et al. (2018) Measuring perceptions related to e-cigarettes: Important principles and next steps to enhance study validity. Addict Behav 79:219-225|
|Shang, Ce; Weaver, Scott R; Zahra, Nahleen et al. (2018) The Association between Potential Exposure to Magazine Ads with Voluntary Health Warnings and the Perceived Harmfulness of Electronic Nicotine Delivery Systems (ENDS). Int J Environ Res Public Health 15:|
|Dutra, Lauren McCarl; Nonnemaker, James; Taylor, Nathaniel et al. (2018) Deception and Shopping Behavior Among Current Cigarette Smokers: A Web-Based, Randomized Virtual Shopping Experiment. JMIR Res Protoc 7:e10468|
|Barrington-Trimis, Jessica L; Gibson, Laura A; Halpern-Felsher, Bonnie et al. (2018) Type of E-Cigarette Device Used Among Adolescents and Young Adults: Findings From a Pooled Analysis of Eight Studies of 2166 Vapers. Nicotine Tob Res 20:271-274|
|Popova, Lucy; Lempert, Lauren Kass; Glantz, Stanton A (2018) Light and mild redux: heated tobacco products' reduced exposure claims are likely to be misunderstood as reduced risk claims. Tob Control 27:s87-s95|
|Popova, Lucy; Majeed, Ban; Owusu, Daniel et al. (2018) Who are the smokers who never plan to quit and what do they think about the risks of using tobacco products? Addict Behav 87:62-68|
|Nyman, Amy L; Weaver, Scott R; Popova, Lucy et al. (2018) Awareness and use of heated tobacco products among US adults, 2016-2017. Tob Control 27:s55-s61|
|Popova, Lucy; Owusu, Daniel; Weaver, Scott R et al. (2018) Affect, risk perception, and the use of cigarettes and e-cigarettes: a population study of U.S. adults. BMC Public Health 18:395|
|Berman, Micah L; Zettler, Patricia J; Ashley, David L (2018) Anticipating Industry Arguments: The US Food and Drug Administration's Authority to Reduce Nicotine Levels in Cigarettes. Public Health Rep 133:502-506|
Showing the most recent 10 out of 50 publications